MCM
MNTA

Matarin Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Matarin Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-159,527
Closed -$2.23M – 320
2017
Q4 		$2.23M Sell
159,527
-79,183
-33% -$1.07M 0.17% 167
2017
Q3 		$4.42M Buy
238,710
+17,797
+8% +$298K 0.38% 108
2017
Q2 		$3.73M Buy
220,913
+116,538
+112% +$1.77M 0.35% 129
2017
Q1 		$1.39M Buy
+104,375
New +$1.63M 0.14% 183
2014
Q1 		– Sell
-97,728
Closed -$1.73M – 178
2013
Q4 		$1.73M Buy
97,728
+32,621
+50% +$548K 1.06% 43
2013
Q3 		$937K Buy
65,107
+12,969
+25% +$198K 0.79% 56
2013
Q2 		$785K Buy
+52,138
New +$688K 0.79% 48

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return